Prasugrel-d4
Modify Date: 2024-04-05 17:41:29
Prasugrel-d4 structure
|
Common Name | Prasugrel-d4 | ||
|---|---|---|---|---|
| CAS Number | 1189919-49-0 | Molecular Weight | 377.46600 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C20H16D4FNO3S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Prasugrel-d4Prasugrel-d4 is the deuterium labeled Prasugrel[1]. Prasugrel (PCR 4099), a thienopyridine and prodrug, inhibits platelet function. Prasugrel is an orally active and potent P2Y12 receptor antagonist, and inhibits ADP-induced platelet aggregation[2]. |
| Name | [5-[1-(2-fluorophenyl)-2-oxo-2-(2,2,3,3-tetradeuteriocyclopropyl)ethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] acetate |
|---|---|
| Synonym | More Synonyms |
| Description | Prasugrel-d4 is the deuterium labeled Prasugrel[1]. Prasugrel (PCR 4099), a thienopyridine and prodrug, inhibits platelet function. Prasugrel is an orally active and potent P2Y12 receptor antagonist, and inhibits ADP-induced platelet aggregation[2]. |
|---|---|
| Related Catalog | |
| In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
| References |
| Molecular Formula | C20H16D4FNO3S |
|---|---|
| Molecular Weight | 377.46600 |
| Exact Mass | 377.14000 |
| PSA | 74.85000 |
| LogP | 3.82890 |
| Prasugrel-d5 |
| CS 747 |